Metropolitan Life Insurance CO Immunity Bio, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$3.23 - $6.17 $5,310 - $10,143	-1,644 Reduced 21.4%	6,038 $32,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $2,027 - $8,450	1,622 Added 26.77%	7,682 $38,000
Q2 2023 Aug 10, 2023	BUY	$1.53 - $6.41 $2,249 - $9,422	1,470 Added 32.03%	6,060 $16,000
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $490 - $1,735	-363 Reduced 7.33%	4,590 $8,000
Q4 2022 Jun 14, 2023	BUY	$4.35 - $6.77 $1,579 - $2,457	363 Added 7.91%	4,953 $25.1 Million
Q3 2022 Jun 14, 2023	BUY	$3.65 - $6.43 $1,324 - $2,334	363 Added 7.91%	4,953 $24.6 Million
Q3 2022 Mar 30, 2023	BUY	$3.65 - $6.43 $11,347 - $19,990	3,109 Added 168.6%	4,953 $24,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $11,347 - $19,990	3,109 Added 168.6%	4,953 $25,000
Q2 2022 Jun 20, 2023	SELL	$2.68 - $6.14 $7,359 - $16,860	-2,746 Reduced 59.83%	1,844 $6,000
Q2 2022 Mar 30, 2023	SELL	$2.68 - $6.14 $7,517 - $17,222	-2,805 Reduced 60.34%	1,844 $6,000
Q2 2022 Aug 11, 2022	SELL	$2.68 - $6.14 $7,517 - $17,222	-2,805 Reduced 60.34%	1,844 $7,000
Q1 2022 Jun 20, 2023	BUY	$5.05 - $7.53 $297 - $444	59 Added 1.29%	4,649 $26,000
Q1 2022 Mar 30, 2023	SELL	$5.05 - $7.53 $71,836 - $107,114	-14,225 Reduced 75.37%	4,649 $26,000
Q1 2022 May 12, 2022	SELL	$5.05 - $7.53 $71,836 - $107,114	-14,225 Reduced 75.37%	4,649 $26,000
Q4 2021 Jun 21, 2023	BUY	$5.67 - $10.18 $80,990 - $145,411	14,284 Added 311.2%	18,874 $114,000
Q4 2021 Mar 30, 2023	SELL	$5.67 - $10.18 $1,865 - $3,349	-329 Reduced 1.71%	18,874 $114,000
Q4 2021 Feb 15, 2022	SELL	$5.67 - $10.18 $1,865 - $3,349	-329 Reduced 1.71%	18,874 $115,000
Q3 2021 Jun 21, 2023	BUY	$9.17 - $14.24 $134,001 - $208,089	14,613 Added 318.37%	19,203 $187,000
Q2 2021 Jun 21, 2023	BUY	$13.41 - $22.4 $195,960 - $327,331	14,613 Added 318.37%	19,203 $274,000
Q2 2021 Mar 30, 2023	BUY	$13.41 - $22.4 $130,506 - $217,996	9,732 Added 102.76%	19,203 $274,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $257,391 - $429,945	19,194 Added 213266.67%	19,203 $274,000
Q1 2021 Jun 26, 2023	BUY	$12.83 - $42.25 $62,623 - $206,222	4,881 Added 106.34%	9,471 $225 Million
Q1 2021 Mar 30, 2023	BUY	$12.83 - $42.25 $57,965 - $190,885	4,518 Added 91.22%	9,471 $224,000
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $115 - $380	9 New	9 $225,000

Others Institutions Holding IBRX

# of Institutions

204

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account